当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 现金流量表

和邦生物

(603077)

  

流通市值:183.70亿  总市值:183.70亿
流通股本:88.32亿   总股本:88.32亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,387,050,369.412,183,959,713.871,101,227,572.596,427,623,560.58
  收到的税费返还161,538,071.13147,169,671.7420,445,349.14113,708,087.09
  收到其他与经营活动有关的现金70,544,515.4149,548,481.4725,783,283.97115,259,286.05
  经营活动现金流入小计3,619,132,955.952,380,677,867.081,147,456,205.76,656,590,933.72
  购买商品、接受劳务支付的现金2,425,662,182.831,649,634,114.48872,209,683.354,303,989,899.48
  支付给职工以及为职工支付的现金436,368,001.76303,521,693.07170,823,845.22635,026,864
  支付的各项税费267,719,611.6172,010,810.2849,205,694.34489,486,461.8
  支付其他与经营活动有关的现金102,102,070.5766,430,761.2932,603,069.8151,851,097.29
  经营活动现金流出小计3,231,851,866.762,191,597,379.121,124,842,292.715,580,354,322.57
  经营活动产生的现金流量净额387,281,089.19189,080,487.9622,613,912.991,076,236,611.15
二、投资活动产生的现金流量:
  收回投资收到的现金---77,052,422.39
  取得投资收益收到的现金9,777,640.639,777,640.631,120,0001,853,787.83
  处置固定资产、无形资产和其他长期资产收回的现金净额275,335.76251,347.65237,694.76992,672.44
  收到的其他与投资活动有关的现金31,881,776.5319,487,374.959,934,778.52115,464,579.25
  投资活动现金流入小计41,934,752.9229,516,363.2311,292,473.28195,363,461.91
  购建固定资产、无形资产和其他长期资产支付的现金1,097,555,158.98657,246,389.95253,023,190.11,258,913,532.7
  投资支付的现金---97,698,304.42
  支付其他与投资活动有关的现金11,572,582.091,330,0001,330,000187,315,553.71
  投资活动现金流出小计1,109,127,741.07658,576,389.95254,353,190.11,543,927,390.83
  投资活动产生的现金流量净额-1,067,192,988.15-629,060,026.72-243,060,716.82-1,348,563,928.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金---120,000
  其中:子公司吸收少数股东投资收到的现金---120,000
  取得借款收到的现金2,654,760,950.952,017,800,0001,501,600,0003,900,876,713.76
  收到其他与筹资活动有关的现金1,298,659,245.721,056,002,317.8372,885,716.1273,931,506.57
  筹资活动现金流入小计3,953,420,196.673,073,802,317.831,574,485,716.123,974,928,220.33
  偿还债务支付的现金2,312,256,541.471,961,676,197.041,170,516,373.723,367,733,749.29
  分配股利、利润或偿付利息支付的现金93,297,398.4463,545,682.4831,713,434.26135,774,305.33
  其中:子公司支付给少数股东的股利、利润---22,632.74
  支付其他与筹资活动有关的现金12,328,027.737,574,830.322,993,932.71327,996,857.27
  筹资活动现金流出小计2,417,881,967.642,032,796,709.841,205,223,740.693,831,504,911.89
  筹资活动产生的现金流量净额1,535,538,229.031,041,005,607.99369,261,975.43143,423,308.44
四、汇率变动对现金及现金等价物的影响-73,624,596.32-51,286,958.09-24,821,057.89-38,462,235.45
五、现金及现金等价物净增加额782,001,733.75549,739,111.14123,994,113.71-167,366,244.78
  加:期初现金及现金等价物余额6,684,196,816.016,684,196,816.016,681,673,478.826,851,563,060.79
  期末现金及现金等价物余额7,466,198,549.767,233,935,927.156,805,667,592.536,684,196,816.01
补充资料:
  净利润-374,581,964.58--712,664,631.51
  资产减值准备-39,700,767.03-763,172,731.83
  固定资产和投资性房地产折旧-433,371,291.69-930,216,134.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-433,371,291.69-930,216,134.69
  无形资产摊销-21,782,249.19-66,863,984.74
  长期待摊费用摊销-196,226.4-392,452.8
  处置固定资产、无形资产和其他长期资产的损失--7,434.41-4,361,435.6
  固定资产报废损失-12,323.56-13,504,372.43
  财务费用-93,124,283.72-143,505,434.15
  投资损失--6,847,995.08-5,005,111.27
  递延所得税-18,249,833.02--35,615,185.21
  其中:递延所得税资产减少-8,253,350.36--23,269,744.9
    递延所得税负债增加-9,996,482.66--12,345,440.31
  存货的减少--435,662,321.97-304,245,999.79
  经营性应收项目的减少--277,616,222.8-540,438,280.37
  经营性应付项目的增加--95,999,229.49--990,581,733.63
  其他-5,541,392.07-15,913,023.62
  现金的期末余额-7,233,935,927.15-6,684,196,816.01
  减:现金的期初余额-6,684,196,816.01-6,851,563,060.79
  现金及现金等价物的净增加额-549,739,111.14--167,366,244.78
公告日期2026-10-272026-08-182026-04-212026-04-21
审计意见(境内)标准无保留意见
TOP↑